Connect with us
Almirall reduced its net profit by 58.3% until the third quarter of 2023, with a figure of €14.4 million, compared to the 34.5 million euros registered...
The gross margin of 64.9% has also been in line with expectations, reflecting the impact of the high cost of production goods and inflation that has...
Almirall is a global biopharmaceutical company focused on medical dermatology. We collaborate with scientists and healthcare professionals to address patient needs through science to improve their...
Almirall will obtain a license to use EpimAb's patented Fabs-In-Tandem Immunoglobulin (FIT-Ig) platform. The Spanish pharmaceutical company reduced its profit by 56% in the first half...
Reig Jofre is the only one that does not follow the upward trend of the Spanish pharmaceutical sector and closes the third quarter with a decrease...
The Catalan pharmaceutical company Almirall earned €4.3 million in 2022 and surpassed the losses of €40.9 million it had in 2021. The normalized net result, which...
Reig Jofre reported a profit of €4.2 million between January and September 2022, 16% less than in the same period of 2021. The company justifies this...
Following these results, Almirall has confirmed its financial estimates for 2022. Investment in research and development (R&D) increased by 11.3% in the period, to €71.6 million...
Rovi's increase was mainly driven by the strength of the third-party manufacturing business, which grew by 167%. Farma posted a net profit of $28 million (€26.6...
The six listed pharmaceutical companies close the first quarter of 2022 with a stock market value of $16.7 billion (€15.1 billion). The biggest decline was registered...